An integrated approach to uncover quality markers of Traditional Chinese medicine underlying chemical profiling, network target selection and metabolomics approach: Guan-Xin-Jing capsule as a model

Guanhua Zhang,Qi Wang,Xin Liu,Xu Wang,Wenyu Xie,Kun Liu,Wujun Jiang,Chenglin Mu,Huanyang Qi,Qiao Wang
DOI: https://doi.org/10.1016/j.jpba.2020.113413
IF: 3.571
2020-10-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:<p>The "multi-component and multi-target" property of traditional Chinese medicine (TCM) makes the quality control more difficult, which remains a key concern hindering the space of progress in its modernization and globalization. This study aims to provide a new strategy to discover quality markers related to the efficacy and stability of TCM based on the bioactive markers finding and differential markers finding, Guan-Xin-Jing capsule (GXJC) was used as a model. Firstly, the UHPLC-QTOF-MS/MS was performed to identify the chemical profiling of GXJC and 148 compounds were unequivocally or tentatively identified. Subsequently, the compounds with relatively low intensity, low oral bioavailability and unsuited drug likeness were removed. In addition, a network based approach by integrating candidate compound genes and disease genes was applied to further filter out the potential active compounds against coronary heart disease (CHD) and finally 7 compounds were identified as the potential bioactive markers. Moreover, to ensure the batch-to-batch consistency of GXJC, an untargeted UHPLC-QTOF-MS/MS based metabolomics approach and multivariate statistical analysis was performed and 5 compounds were identified as the potential differential markers to illustrate the discrepancy among 27 batches of GXJC. Using these strategies above, a total of 11 chemical compounds in GXJC were screened out as quality markers(Q-markers). The information generated with our strategy should be more helpful to guide the selection of the Q-markers and lay the foundation for quality control of TCM.</p>
pharmacology & pharmacy,chemistry, analytical
What problem does this paper attempt to address?
The paper attempts to address the issue of quality control in traditional Chinese medicine (TCM). Specifically, due to the complex composition of TCM, its multi-component and multi-target characteristics make it difficult for quality evaluation methods to meet the requirements of stability and controllability. This has become a major obstacle to the modernization and internationalization of TCM. The study aims to propose a new strategy to identify quality markers (Q-markers) that reflect the stability and efficacy of TCM through the discovery of bioactive markers and differential markers, in order to promote the quality control of TCM. The study uses Guanxinning Capsule (GXJC) as an example, which is composed of 9 kinds of Chinese herbs and is used to treat coronary heart disease. The research integrates chemical profiling analysis, ADME prediction, and network target selection methods to identify bioactive markers, and employs non-targeted UHPLC-QTOF-MS/MS metabolomics methods and multivariate statistical analysis to identify differential markers, ultimately screening out 11 compounds as quality markers for GXJC. These strategies provide new ideas and methods for the quality control of TCM.